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The two-stage group testing method is examined and its application
in COVID-19 is discussed. The expected false positive rate and false
negative rate are calculated for given values of sensitivity, specificity,
prevalence and group-testing parameters. To reduced false negative
rate, we suggest to test the pooled sample multiple times at the first
stage.
1 Procedures and Efficacy of Two-stage Group Testing
The task is to test N individuals to determine whether each individual is infected by
some disease or not by using the two-stage group testing strategy. An overview of group
testing can be found in [1]. Denote p as the infection probability, which is the prevalence
parameter of the epidemics. Denote ρ, q as the sensitivity and specificity of the test,
respectively, which are parameters of the test itself.1 The procedures of two-stage group
test is described in Algorithm 1.
Such method has been adopted in Israel [2], Nebraska and Germany [3]. There are
also studies which discuss the application of different group testing algorithms in COVID-
19 [4, 5, 6].
The motivation of testing each pool for m times in Step 7 of Algorithm 1 is due to
the concern of high false negative rate of the RT-PCR test for COVID-19 [7, 8]. If a
pool contains several infected specimens but was falsely tested as negative, then all the
infected individuals in this pool will be misclassified, which effectively increases the false
negative rate even further. More precisely, we found (see the theory section below) that
introducing the two-stage group testing improves the performance of testing positives
(positive predictive value PPV becomes higher and false positive rate FPR becomes
1The sensitivity ρ indicates the probability of obtaining a positive result when testing on an infected
individual, while the specificity q indicates the probability of obtaining a negative result when testing
on a healthy individual.
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Algorithm 1 Procedures of two-stage group test.
Inputs: N specimens, sensitivity ρ, specificity q, estimated prevalence parameter p
1: On the basis of the developed theory, determine the pool size k, number of pools
N/k, and number of tests m performed on each pool.
2: Partition the N specimens into N/k non-overlapping pools, where each pool has k
specimens.
3: Divide each specimen into m+ 1 fractions.
4: for i = 1 to N/K do
5: In the i-th pool, take a specimen fraction of each individual and mix them into
one big sample.
6: Test the big sample of the pool and record the test result.
7: Repeat Step 5 and Step 6 for m times.
8: if all the m tests of the pool are negative then
9: Mark all k individuals of the i-th pool as negative.
10: else
11: Test all k specimens of the i-th pool individually and record the results.
12: end if
13: end for
Outputs: test results of N specimens.
lower), while it degrades the performance of testing negatives (negative predictive value
NPV becomes lower and false negative rate FNR becomes higher).
To determine the parameters in Step 1 of Algorithm 1, one way is to minimize the
expected number of tests T , subject to some accuracy constraints. To be more specific,
we consider the case ρ = 0.9, q = 0.999 (high specificity but moderate sensitivity), which
is relevant in testing of COVID-19. For individual test, the false negative rate FNR =
1−ρ = 10%. We found in theory (Eq. (24) below) that for two-stage group test, expected
FNR only depends on ρ and m. For group test with m = 1, FNR = 1 − ρ2 = 19%,
which is much higher than the case of individual test. However, if m = 2 is used, then
expected FNR = 10.9%; if m = 3 is used, expected FNR = 10.09%. Therefore, testing
a pool multiple times can reduce the FNR to similar level of individual test. Generally
speaking, a higher m is needed for a lower sensitivity ρ. For ρ = 0.9, we suggest to choose
m = 2 or m = 3, and minimize number of tests T in Eq. (20) with respect to k. An
example is shown in Table. 1. It is shown that a significant number of tests can be saved
while maintaining a similar level of statistical performance.
Notice that in developing the theory, we assume the sensitivity ρ and specificity q are
constant irrespective of sample dilution, which needs to be examined [9, 10, 11, 12].
2 Theory and Determination of Parameters
In this section, we outline the theory of two-stage group test, which can be used to
determine the parameters needed for implementation. Note that only average behaviors
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p m k T/N PPV NPV FPR FNR
0.01 1 100% 0.9009 0.99899 0.001 0.1
0.01 2 15 27.3% 0.9856 0.99890 0.0001317 0.109
0.01 3 19 33.4% 0.9819 0.99898 0.0001678 0.1009
0.02 1 100% 0.9484 0.99796 0.001 0.1
0.02 2 11 38.1% 0.9901 0.99778 0.0001827 0.109
0.02 3 14 46.3% 0.9875 0.99794 0.0002331 0.1009
Table 1: Optimal parameters of group testing, compared to individual testing (k = 1).
Parameters are ρ = 0.9, q = 0.999. A significant number of tests can be saved
while maintaining a similar level of statistical performance. For example, when
p = 0.01, using group-testing with parameters m = 2, k = 15 only requires
27.3% testing resources of individual testing, while keeping a similar level of
FPR and FNR.
are studied, while fluctuations are not considered. Some quantities of interests are
T = E(number of tests), (1)
PPV = positive predictive value =
E(number of true test positives)
E(number of test positives)
=
E(number of true test positives)
E(number of true test positives) + E(number of false positives)
, (2)
NPV = negative predictive value =
E(number of true test negatives)
E(number of test negatives)
=
E(number of true test negatives)
E(number of true test negatives) + E(number of false negatives)
, (3)
FPR = false positive rate =
E(number of false positives)
E(number of healthy individuals)
, (4)
FNR = false negative rate =
E(number of false negatives)
E(number of infected individuals)
. (5)
If the infection probability (prevalence parameter) is p, we have
E(number of infected individuals) = Np, (6)
E(number of healthy individuals) = N(1− p). (7)
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2.1 Theory of Individual Test
For conventional individual test method (i.e., k = 1), each individual is tested once. The
quantities of interests are computed as
T = N, (8)
PPV =
pρ




(1− p)q + p(1− ρ)
, (10)
FPR = 1− q, (11)
FNR = 1− ρ. (12)
2.2 Theory of Group Test
For two-stage group testing (i.e., k > 1) as described, some relevant quantities are
computed as











E(number of infected individuals inside an infected group)
=
E(number of infected individuals)





















































=N(1− p)k(1− qm)(1− q) +N
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(1− p)k · qm · k +
N
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E(number of true test positives)
E(number of true test positives) + E(number of false positives)
, (21)
NPV =
E(number of true test negatives)





















· (1− ρ). (24)
The group-testing parameters m,k can be determined based on these quantities of
interests, primarily by minimizing T while controlling FPR and FNR, as was done in
Table 1.
2.3 Some Observations
In Fig. 1, we demonstrate the effect of group testing on FPR and FNR. Comparing to
individual testing, group testing reduces FPR, but increases FNR. However, FNR can
be controlled with a relatively small m.
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Figure 1: (a) FPR vs q. Parameters are p = 0.01, ρ = 0.9, k = 10. Comparing
to individual testing, group testing reduces FPR. FPR increases with m.
(b) FNR vs ρ. Parameters other than ρ and m are irrelevant. Comparing
to individual testing, group testing increases FNR. However, FNR can be
controlled with a relatively small m.
In Fig. 2, we contrast the theory to simulation; it demonstrates a good match of average
behaviors between the two approaches, while fluctuations are large. On average, group
testing improves PPV but degrades NPV slightly comparing to individual testing; it
also reduces FPR but increases FNR.
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Figure 2: Solid line: theory; dash line with error bar: simulation (each data point is
averaged over 100 realizations). Parameters are N = 1000, ρ = 0.9, q =
0.999,m = 2. (a) T vs k. Group testing reduces the expected number of
tests required when k > 2. (b) PPV vs k. (c) NPV vs k. (d) FPR vs k. (e)
FNR vs k.
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